Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia.

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia.

This study of children and adults with acute lymphoblastic leukaemia (ALL) is the largest series of patients with hypodiploidy (<46 chromosomes) yet reported. The incidence of 5% was independent of age. Patients were subdivided by the number of chromosomes; near-haploidy (23-29 chromosomes),...

Full description

Bibliographic Details
Main Authors:	Harrison, C, Moorman, A, Broadfield, Z, Cheung, K, Harris, R, Reza Jalali, G, Robinson, H, Barber, K, Richards, S, Mitchell, C, Eden, T, Hann, I, Hill, F, Kinsey, SE, Gibson, B, Lilleyman, J, Vora, A, Goldstone, A, Franklin, I, Durrant, J, Martineau, M
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia in UK MRC trials.
by: Harrison, C, et al.
Published: (2003)

TEL-AML1 fusion in childhood acute lymphoblastic leukaemia (ALL): Demographics, clinical features, cytogenetic characteristics and prognosis
by: Moorman, A, et al.
Published: (2005)

Intraocular relapse of childhood acute lymphoblastic leukaemia.
by: Somervaille, T, et al.
Published: (2003)

Refractory acute monoblastic leukaemia with low hypodiploidy
by: Lum, S.H., et al.
Published: (2014)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
by: Hann, I, et al.
Published: (2000)

Blast cell vacuoles in childhood lymphoblastic leukaemia.
by: Lilleyman, J, et al.
Published: (1988)

Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial.
by: Moorman, A, et al.
Published: (2003)

Late relapsing childhood lymphoblastic leukaemia.
by: Frost, L, et al.
Published: (1997)

Late relapsing childhood acute lymphoblastic leukaemia.
by: Frost, L, et al.
Published: (1998)

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.
by: Vora, A, et al.
Published: (2006)

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
by: Mitchell, C, et al.
Published: (2005)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
by: Eden, O, et al.
Published: (1998)

Variables affecting kinetics of minimal residual disease clearance in children with lymphoblastic leukaemia; Results of the United Kingdom Medical Research Council (UK MRC) protocols ALL97, ALL97/99 and ALL2003.
by: Vora, A, et al.
Published: (2005)

French American British (FAB) morphological classification of childhood lymphoblastic leukaemia and its clinical importance.
by: Lilleyman, J, et al.
Published: (1986)

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.
by: Moorman, A, et al.
Published: (2003)

Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97.
by: Lennard, L, et al.
Published: (2005)

Thioguanine-related veno-occlusive disease (VOD) of the liver in children with acute lymphoblastic leukaemia (ALL): Report from United Kingdom Medical Research Council (UK MRC) trial ALL97.
by: Vora, A, et al.
Published: (2002)

Benefit of targeted intensification for NCI high risk childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council trial ALL97 and ALL97/99.
by: Vora, A, et al.
Published: (2006)

Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood Leukaemia.
by: Lilleyman, J, et al.
Published: (1992)

Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).
by: Hill, F, et al.
Published: (2004)

Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics
by: Moorman, A, et al.
Published: (2012)

Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia.
by: Lilleyman, J, et al.
Published: (1997)

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.
by: Eden, O, et al.
Published: (2000)

Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI).
by: Hargrave, DR, et al.
Published: (2001)

Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods.
by: Eden, O, et al.
Published: (1990)

The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers
by: Lennard, L, et al.
Published: (2010)

Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII study.
by: Rai, L, et al.
Published: (2010)

The Spectrum and Prognostic Relevance of Additional Abnormalities, Involving 12p and 21q, in Children with ETV6-RUNX1 Positive Acute Lymphoblastic Leukaemia (ALL)
by: Moorman, A, et al.
Published: (2008)

Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
by: Ramanujachar, R, et al.
Published: (2007)

Intraocular relapse of childhood acute lymphoblastic leukemia.
by: Somervaille, T, et al.
Published: (2002)

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997
by: Eden, O, et al.
Published: (2000)

Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.
by: Krishnan, S, et al.
Published: (2010)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
by: Chessells, J, et al.
Published: (1994)

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
by: Chessells, J, et al.
Published: (1995)

Near-Haploidy and Low-Hypodiploidy in B-Cell Acute Lymphoblastic Leukemia: When Less Is Too Much
by: Oscar Molina, et al.
Published: (2021-12-01)

The clinical pharmacology of thioguanine vs. mercaptopurine in ALL97, a randomized trial for the treatment of childhood lymphoblastic leukaemia
by: Lennard, L, et al.
Published: (2008)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia
by: Moorman, A, et al.
Published: (2007)

No association of HLA-A supertype with outcome in childhood acute lymphoblastic leukaemia: results of the UKALL XI trial.
by: Thompson, P, et al.
Published: (2011)

Acute lymphoblastic leukaemia has a poor outcome in children with Down syndrome due to infective death in remission - (Results of UK MRC ALL 97 trial).
by: de la Fuente, J, et al.
Published: (2005)

UKALL XI randomised trial stratified CNS treatments and prospective neuropsychological assessment in childhood acute lymphoblastic leukaemia (ALL).
by: Hill, F, et al.
Published: (2000)